Results 21 to 30 of about 710,167 (255)

Synthesis, in Vitro Pharmacology, and Molecular Modeling of Very Potent Tacrine−Huperzine A Hybrids as Acetylcholinesterase Inhibitors of Potential Interest for the Treatment of Alzheimer's Disease [PDF]

open access: yes, 1999
Eleven new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivatives [tacrine (THA)−huperzine A hybrids, rac-21−31] have been synthesized as racemic mixtures and tested as acetylcholinesterase (AChE) inhibitors.
Badia, Albert   +21 more
core   +1 more source

Acetylcholinesterase and α-Amylase inhibitors from Mouriri elliptica Martius leaf extract

open access: yesBioscience Journal, 2020
Population growth has raised food production, and new sources are needed to increase quantity and quality of agricultural products. Carbamates and organophosphates are insecticide classes used worldwide as acetylcholinesterase (AChE) inhibitors.
Letícia Siqueira da Silva   +4 more
doaj   +3 more sources

Some aspects of treatment of neurodegenerative dementias

open access: yesМедицинский совет, 2014
The article is devoted to certain issues in the treatment of neurodegenerative dementias. The effectiveness of acetylcholinesterase inhibitors and drugs from other pharmacological groups, as well as combination therapy with inhibitors of ...
I. S. Preobrazhenskaya, D. O. Gromova
doaj   +1 more source

2-Mercaptobenzimidazole clubbed hydrazone for Alzheimer’s therapy: In vitro, kinetic, in silico, and in vivo potentials

open access: yesFrontiers in Pharmacology, 2022
Alzheimer’s is a type of dementia that affects the affected person’s thinking, memory, and behavior. It is a multifactorial disease, developed by the breakdown of the neurotransmitter acetylcholine via acetylcholinesterase (AChE).
Farida Begum   +7 more
doaj   +1 more source

Acetylcholinesterase inhibitors in Alzheimer’s disease [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1999
Alzheimer’s Disease (AD) is the most common single cause of dementia in our ageing society. Traditionally thought of as an untreatable degenerative condition, recent advances in drug therapy have challenged this view. The disease is characterised by an insidious decline in cognitive and non-cognitive function. Classically, short and long-term memory
McGleenon, B M   +2 more
openaire   +2 more sources

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2023
Alzheimer’s disease (AD) is a progressive brain disease characterised by progressive memory loss and cognition impairment, ultimately leading to death. There are three FDA-approved acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine,
Dajiang Zou   +5 more
doaj   +1 more source

Upregulation of alpha 7 nicotinic receptors by acetylcholinesterase c-terminal peptides [PDF]

open access: yes, 2009
Background: The alpha-7 nicotinic acetylcholine receptor (alpha 7-nAChR) is well known as a potent calcium ionophore that, in the brain, has been implicated in excitotoxicity and hence in the underlying mechanisms of neurodegenerative disorders such as ...
Bond, Cherie E.   +13 more
core   +2 more sources

The Pupil Diameter as a Possible Indicator of Neurodegenerative Diseases and Response to Acetylcholinesterase Inhibitors Therapy: In-Depth Measurements Following Topical Administration of Tropicamide and Pilocarpine

open access: yesAmerican Journal of Alzheimer's Disease and Other Dementias, 2020
Background: The aim of this study is to assess whether pupillary modifications following ocular anticholinergic and cholinergic drugs can identify subjects with neurodegenerative diseases from early stages. Methods: 51 subjects were divided into 3 groups,
Raffaele Nuzzi MD   +5 more
doaj   +1 more source

Acetylcholinesterase inhibitors attenuate angiogenesis [PDF]

open access: yesClinical Science, 2012
Donepezil {(RS)-2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one} is a reversible acetylcholinesterase inhibitor and used for treatment of patients with AD (Alzheimer's disease). Recent studies showed that treatment with donepezil reduced production of inflammatory cytokines in PBMCs (peripheral blood mononuclear cells).
Miyazaki, Ryohei   +8 more
openaire   +2 more sources

One‐Pot Biphasic Photocatalytic CO2‐to‐Carbonylation Cascades

open access: yesAngewandte Chemie, EarlyView.
Bioinspired biphasic compartmentalization enables one‐pot cascades where photocatalytic CO2 reduction generates CO for carbonylative cross‐couplings to synthesize complex organic products, including a pharmaceutical. ABSTRACT Photosynthesis compartmentalizes reactions across the thylakoid membrane in vivo to upcycle CO2 into complex chemicals that are ...
Sampurna Mitra   +3 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy